Skip to main content
Premium Trial:

Request an Annual Quote

Kathy Ordoñez

Pacific Biosciences has hired Kathy Ordoñez as chief commercial officer. Ordoñez has been a member of PacBio's board of directors since 2014 and will continue in that role, as well. Ordoñez was most recently CEO of RainDance Technologies. She was also previously senior vice president at Quest Diagnostics where she led the company's R&D efforts and provided oversight to businesses commercializing diagnostic products and testing services. She served as CEO at Celera and was a founder of Celera Diagnostics before the company was acquireid by Quest Diagnostics. She also held several positions at Hoffmann-La Roche, including overseeing the formation of Roche Molecular Systems.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.